462 filings
Page 10 of 24
6-K
qp5qp5c mf15ds85
28 Apr 21
Results of Annual General Meeting
9:37am
6-K
hs69agk0x fealn
23 Apr 21
Vesting of awards under the Long Term Incentive Plan
6:30am
6-K
akt 97kqu34l
14 Apr 21
Notification of Dilution of Voting Rights
6:22am
6-K
2nct78k
8 Apr 21
HUTCHMED Announces US$100 Million Equity Investment by Baring Private Equity Asia
6:11am
6-K
q5wf46
31 Mar 21
Current report (foreign)
7:02am
6-K
vdivvnq
29 Mar 21
Current report (foreign)
6:28am
6-K
yhjmoz2yg7krk4c4v
26 Mar 21
2020 Annual Report and Notice of Annual General Meeting
6:31am
6-K
tdunj5
24 Mar 21
HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169 Million
9:33am
6-K
mdweaz wsl9
24 Mar 21
Current report (foreign)
6:55am
6-K
nw4c6s539b 63p2h75
10 Mar 21
Vesting of awards under the Long Term Incentive Plan
6:07am
6-K
rxo458vatbu pemf
4 Mar 21
Hutchison China MediTech Limited Reports 2020 Full Year Results and Provides Business Updates and Evolves Corporate Identity
9:21am
6-K
r0yrg
3 Feb 21
Chi-Med to Announce 2020 Final Results
6:13am
6-K
hvitlivx1jfb002w
14 Jan 21
Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC
6:07am
6-K
g09u ssad
11 Jan 21
Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases
6:07am
6-K
hxwm3mmf
31 Dec 20
Current report (foreign)
6:57am
6-K
a1157rsz86 qq
29 Dec 20
Chi-Med Initiates Rolling Submission of NDA to U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors
6:45am
6-K
plr7xi nbn
22 Dec 20
Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference
6:10am
6-K
9y0b46vf3cppn3i4wr
15 Dec 20
Current report (foreign)
6:14am
6-K
8qcng608tw 65teac
30 Nov 20
Current report (foreign)
6:28am